Omaveloxolone | m-entrepreneurship.com

Product Name :
Omaveloxolone

Search keywords :
NFE2

drugId :
null

Target Vo:
Nuclear factor erythroid 2-related factor 2

Target Vo Short Name :
Nrf2

Moa_Name:
Nuclear factor erythroid 2-related factor 2 stimulants

First Approval Country :
United States

First Approval Date Filter:
2023

Origin Company_Name :
Dartmouth College

Active Company_Name :
Abbvie Inc

Active Indication_Name:
Friedreich Ataxia

In Active Indication_Name:
Cataract

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Alexa Fluor® 594-conjugated AffiniPure Goat Anti-Mouse IgG H&L
Caspase-6 p18 Antibody
p53 DINP1 Antibody: p53 DINP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 27 kDa, targeting to p53 DINP1. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts